eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Syner-Med (Pharmaceutical Products) Ltd

Beech House, 840 Brighton Road, Purley, Surrey, CR8 2BH
Telephone: +44 (0)845 634 2100
Fax: +44 (0)845 634 2101

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 24/08/2011
SPC Syner-KINASE 10,000 IU, 25,000 IU, 100,000 IU, 250,000 IU, 500,000 IU, 1,000,000 IU

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   06-May-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

SPC harmonised
Updated on 30/07/2009 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
Date of revision of text on the SPC:   22-Jun-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

The infusion dosage has changed from 5,000 IU to UP TO 250,000 IU OVER A PERIOD OF 90 TO 180 MINUTES.

Alternatively, an infusion of up to 250,000IU Syner-KINASE can be administered into the catheter or cannula over  aperiod of 90 to 180 minutes using a solution of 1,000 to 2,500 IU/ml in sterile physiological saline.
Updated on 22/08/2008 and displayed until 30/07/2009
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
  • Change to section 2 - Qualitative and quantitative composition
  • Introduction of new strength
Date of revision of text on the SPC:   15-Aug-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

1. 10,000IU (additional dosage form)
2. 10,000IU (additional dosage form)
3. 10,000IU (additional dosage form) and MAH number
10. Revision date August 2008

Updated on 20/12/2006 and displayed until 22/08/2008
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   human urokinase